We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

229 hedge funds and large institutions have $188M invested in Editas Medicine in 2024 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 68 increasing their positions, 64 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more call options, than puts

Call options by funds: $1.5M | Put options by funds: $1.14M

6% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 64

1.71% less ownership

Funds ownership: 68.57% → 66.86% (-1.7%)

3% less funds holding

Funds holding: 235 → 229 (-6)

12% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 41

29% less capital invested

Capital invested by funds: $263M → $188M (-$75.6M)

Holders
229
Holders Change
-6
Holders Change %
-2.55%
% of All Funds
3.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
36
Increased
68
Reduced
64
Closed
41
Calls
$1.5M
Puts
$1.14M
Net Calls
+$362K
Net Calls Change
-$415K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$3.88M
2
Two Sigma Investments
Two Sigma Investments
New York
+$3.56M
3
APM
Avidity Partners Management
Texas
+$2.83M
4
Jane Street
Jane Street
New York
+$2.5M
5
CSS
Cubist Systematic Strategies
Connecticut
+$2.05M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$9.27M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$5.89M
3
DTC
Deep Track Capital
Connecticut
-$4.79M
4
IHAM
Integral Health Asset Management
New York
-$3.15M
5
Squarepoint
Squarepoint
New York
-$2.62M
Name Holding Trade Value Shares
Change 		Change in
Stake
AF
176
Advisornet Financial
Minnesota
$1.89K – – –
FDCDDQ
177
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.88K +$218 +50 +10%
HCM
178
Hollencrest Capital Management
California
$1.71K -$501 -115 -19%
AWM
179
Ameliora Wealth Management
Switzerland
$1.71K – – –
SC
180
SouthState Corp
Florida
$1.71K – – –
WT
181
Washington Trust
Rhode Island
$1.51K – – –
SPIA
182
Steward Partners Investment Advisory
New York
$1.45K -$1.39K -320 -43%
CA
183
CoreCap Advisors
Michigan
$1.13K -$740 -170 -34%
WT
184
Whittier Trust
California
$1.1K – – –
SCM
185
Sterling Capital Management
North Carolina
$1.07K +$1.36K +313 New
ICM
186
Islay Capital Management
Texas
$1.02K – – –
NFSG
187
Newbridge Financial Services Group
Florida
$1.02K – – –
Daiwa Securities Group
188
Daiwa Securities Group
Japan
$1K – – –
BTI
189
Blue Trust Inc
Georgia
$934 – – –
SSB
190
Sandy Spring Bank
Maryland
$860 +$435 +100 +66%
TFA
191
Toth Financial Advisory
Virginia
$853 – – –
PS
192
Principal Securities
Iowa
$835 +$218 +50 +26%
LFG
193
Larson Financial Group
Missouri
$832 – – –
HPC
194
HM Payson & Co
Maine
$717 – – –
TSMHT
195
Thurston Springer Miller Herd & Titak
Indiana
$699 – – –
GRP
196
Global Retirement Partners
California
$682 -$2.61K -600 -75%
RP
197
Raelipskie Partnership
Ontario, Canada
$682 +$871 +200 New
Comerica Bank
198
Comerica Bank
Texas
$559 +$305 +70 +74%
SIS
199
Sound Income Strategies
Florida
$512 – – –
BBPWM
200
Blue Bell Private Wealth Management
Pennsylvania
$474 – – –
6 7
8
9 10

EDIT Hedge Fund Activity: Q3 2024 in Review

229 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2024, worth a combined $188M — down 29% from $263M a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of EDIT and 36 opened new positions — a net loss of 5 holders — while 64 trimmed existing stakes and 68 added.

The largest buyer was Millennium Management, adding an estimated $3.88M. The largest seller was State Street, cutting an estimated $9.27M.

  • 229 institutional investors held Editas Medicine (EDIT) as of Q3 2024, down from 235 in Q2 2024.
  • Funds reported $188M of Editas Medicine stock for Q3 2024, down 29% quarter-over-quarter.
  • 36 funds opened new Editas Medicine positions in Q3 2024 and 41 closed out, a net change of -5 holders.
  • The largest Editas Medicine buyer in Q3 2024 was Millennium Management, an estimated $3.88M added.
  • The largest Editas Medicine seller in Q3 2024 was State Street, an estimated $9.27M sold.

Based on aggregated 13F filings for Q3 2024.